A significant advance in cancer research is occurring with the use of mini-antibodies to re-engage mutated p53. This essential tumor suppressor protein is frequently disabled in various forms of tumors, resulting https://admiralbookmarks.com/story22038399/vhh-fragments-reactivate-tumor-suppressor-p53-a-potential-hope-for-tumor-management